Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction: Current Management Perspectives

Murad Atmaca Department of Psychiatry, Firat University School of Medicine, Elazig, TurkeyCorrespondence: Murad AtmacaFirat (Euphrates) Universitesi, Firat Tip Merkezi, Psikiyatri Anabilim Dali, Elazig 23119, TurkeyTel +90 424 233 3555Fax +90 424 238 7688Email matmaca_p@yahoo.comAbstract: Any type o...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Atmaca M
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	ssri sexual dysfunction current perspectives Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/e934a7a3842b4e35962f9b9782c049a0
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:e934a7a3842b4e35962f9b9782c049a0
record_format	dspace
spelling	oai:doaj.org-article:e934a7a3842b4e35962f9b9782c049a02021-12-02T11:38:02ZSelective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction: Current Management Perspectives1178-2021https://doaj.org/article/e934a7a3842b4e35962f9b9782c049a02020-04-01T00:00:00Zhttps://www.dovepress.com/selective-serotonin-reuptake-inhibitor-induced-sexual-dysfunction-curr-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Murad Atmaca Department of Psychiatry, Firat University School of Medicine, Elazig, TurkeyCorrespondence: Murad AtmacaFirat (Euphrates) Universitesi, Firat Tip Merkezi, Psikiyatri Anabilim Dali, Elazig 23119, TurkeyTel +90 424 233 3555Fax +90 424 238 7688Email matmaca_p@yahoo.comAbstract: Any type of sexual dysfunction is an important problem in half of the patients with depressive disorder. On the other hand, one to a quarter of people without any depressive disorder experience sexual dysfunction. Antidepressant agents can lead to all types of sexual side effects including arousal, libido, orgasm and ejaculation problems. Selective serotonin reuptake inhibitors (SSRIs) are a widely used class of drugs which are prescribed for the treatment of a variety of disorders, including major depressive disorder, obsessive-compulsive disorder, posttraumatic stress disorder, panic disorder, generalized anxiety disorder, and impulse control disorders. It has been reported that one in eight people have utilized one of the SSRIs in the past 10 years. Some studies reported up to 80% of SSRI-induced sexual side effects. Management of SSRI-induced sexual dysfunction seems to be complex and hard. In this paper, SSRI-induced sexual dysfunction and new perspectives in the management of this problem were reviewed.Keywords: SSRI, sexual dysfunction, current perspectivesAtmaca MDove Medical Pressarticlessrisexual dysfunctioncurrent perspectivesNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 16, Pp 1043-1050 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	ssri sexual dysfunction current perspectives Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
spellingShingle	ssri sexual dysfunction current perspectives Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Atmaca M Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction: Current Management Perspectives
description	Murad Atmaca Department of Psychiatry, Firat University School of Medicine, Elazig, TurkeyCorrespondence: Murad AtmacaFirat (Euphrates) Universitesi, Firat Tip Merkezi, Psikiyatri Anabilim Dali, Elazig 23119, TurkeyTel +90 424 233 3555Fax +90 424 238 7688Email matmaca_p@yahoo.comAbstract: Any type of sexual dysfunction is an important problem in half of the patients with depressive disorder. On the other hand, one to a quarter of people without any depressive disorder experience sexual dysfunction. Antidepressant agents can lead to all types of sexual side effects including arousal, libido, orgasm and ejaculation problems. Selective serotonin reuptake inhibitors (SSRIs) are a widely used class of drugs which are prescribed for the treatment of a variety of disorders, including major depressive disorder, obsessive-compulsive disorder, posttraumatic stress disorder, panic disorder, generalized anxiety disorder, and impulse control disorders. It has been reported that one in eight people have utilized one of the SSRIs in the past 10 years. Some studies reported up to 80% of SSRI-induced sexual side effects. Management of SSRI-induced sexual dysfunction seems to be complex and hard. In this paper, SSRI-induced sexual dysfunction and new perspectives in the management of this problem were reviewed.Keywords: SSRI, sexual dysfunction, current perspectives
format	article
author	Atmaca M
author_facet	Atmaca M
author_sort	Atmaca M
title	Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction: Current Management Perspectives
title_short	Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction: Current Management Perspectives
title_full	Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction: Current Management Perspectives
title_fullStr	Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction: Current Management Perspectives
title_full_unstemmed	Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction: Current Management Perspectives
title_sort	selective serotonin reuptake inhibitor-induced sexual dysfunction: current management perspectives
publisher	Dove Medical Press
publishDate	2020
url	https://doaj.org/article/e934a7a3842b4e35962f9b9782c049a0
work_keys_str_mv	AT atmacam selectiveserotoninreuptakeinhibitorinducedsexualdysfunctioncurrentmanagementperspectives
_version_	1718395795772801024

Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction: Current Management Perspectives

Ejemplares similares